This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Intestinal metaplasia is a type of cellular transformation in which the cells of the stomach lining take on the characteristics of cells found in the small intestine. This occurs when cells in the stomach lining, called gastric mucosa, are exposed to certain environmental factors, such as chronic inflammation or the presence of certain bacteria. Intestinal metaplasia is a precursor to gastric cancer, so it is important to recognize this condition and seek treatment. Intestinal metaplasia cells are normally found in the stomach lining, where they are involved in the production of stomach acid and other substances. However, when the environment of the stomach is altered, these cells can acquire the characteristics of the cells found in the small intestine. This is known as metaplasia, and it is the result of changes in the normal environment of the stomach. The presence of intestinal metaplasia cells can be detected through endoscopic examination of the stomach lining. During this procedure, a thin, flexible tube with a camera is inserted into the stomach, allowing the doctor to examine the lining of the stomach and look for the presence of intestinal metaplasia cells. When intestinal metaplasia cells are found, they are usually treated with antibiotics to kill any bacteria that may be causing the problem. In addition, medications may be prescribed to reduce stomach acid production and reduce inflammation in the stomach lining. In some cases, the presence of intestinal metaplasia cells can be a sign of a more serious condition, such as gastric cancer. Therefore, it is important to seek medical advice and treatment if intestinal metaplasia is found. Early detection and treatment can help to reduce the risk of developing gastric cancer.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States